Law Firm Launches Investigation Into Ashford Hospitality Following Dividend Suspension

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Law firm investigates Ashford Hospitality Trust for potential securities violations following dividend suspension and mortgage disclosure. Stock fell 8.1%.

Law Firm Launches Investigation Into Ashford Hospitality Following Dividend Suspension

Pomerantz LLP has initiated an investigation into potential securities violations by Ashford Hospitality Trust, Inc. (NYSE: AHT) following the company's January 13, 2026 disclosure regarding an extended Highland mortgage loan and the suspension of preferred dividend payments. The announcement prompted an immediate market reaction, with shares declining 8.1% to close at $3.97 per share.

The investigation centers on whether Ashford Hospitality Trust made adequate disclosures regarding its financial condition and liquidity constraints prior to the January announcement. The company's decision to suspend preferred dividends signals a strategic shift in capital allocation priorities aimed at preserving liquidity during a challenging period for the hospitality sector.

Investors who held positions in Ashford Hospitality Trust are encouraged to contact legal counsel to discuss potential claims. The investigation remains in preliminary stages, and no determination has been made regarding the merits of any potential securities claims at this time.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 17

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON